Cyclosporine A-induced mammary hyperplasia and hyperprolactinemia in New Zealand White rabbits

Comparative Medicine

Volumn 51, Issue 5, 2001, Pages 430-435

  Petraitiene, R ^a   Petraitis, V ^a   Bacher, J ^a   Das, S R ^a   Parlow, A F ^a   Walsh, T J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ESTRADIOL; METHYLPREDNISOLONE; PROGESTERONE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST HYPERTROPHY; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HYPERPROLACTINEMIA; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PHYSICAL EXAMINATION; RABBIT;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HUMANS; HYPERPLASIA; HYPERPROLACTINEMIA; IMMUNOSUPPRESSIVE AGENTS; MAMMARY GLANDS, ANIMAL; METHYLPREDNISOLONE; PROGESTERONE; PROLACTIN; RABBITS;

EID: 0035192702     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Guidelines for the use of cyclosporine formulations
2. Impact of RLA matching and cyclosporine on long-term survival in transplanted rabbits
3. Ovarian function, tubal viability and pregnancy after tubo-ovarian transplantation in the rabbit
4. Experimental tracheal allograft revascularization and transplantation
5. A comparison of the effects of rapamycin and cyclosporine on kidney and heart morphology in a rabbit heterotopic heart transplant model
6. Induction of immune tolerance in adult rabbits undergoing heterotopic cardiac transplantation
7. Cyclosporine nephrotoxicity - Experimental models
8. Chronic cyclosporin nephrotoxicity: A rabbit model
9. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model
10. Chronic cyclosporine-induced nephrotoxicity: A rabbit model
11. A comparison of cyclosporine A and cyclosporine G in a rabbit heterotopic cardiac transplant model: Graft outcome and histological findings
12. Acute cyclosporine A-induced nephrotoxicity: A rabbit model
13. Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity
14. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis
15. Therapeutic response of herpes simplex virus-induced corneal edema to trifluridine in combination with immunosuppressive agents
16. The development of corneal edema in herpes simplex virus type l-infected rabbits following termination of therapy for corneal stromal disease
17. Ocular toxoplasmosis: The role of cellular immune defense in the development of recurrences. Results from animal experiments
18. Effects of cyclosporine in experimental cryptococcal meningitis
19. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: Relationship between in vivo and in vitro measurements of cytotoxicity
20. Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis
21. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus
22. Itraconazole for experimental pulmonary aspergillosis: Comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma
23. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression
24. Calcineurin is required for virulence of Cryptococcus neoformans
25. Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits
26. Pharmacological evidence that prolactin acts from late gestation to promote maternal behavior in rabbits
27. Hormones
28. Acute renal failure after heart transplantation and cyclosporine therapy
29. Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: Histopathologic findings of renal allografts with proteinuria
30. Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting
31. Cyclosporine induces epileptiform activity in an in vitro seizure model
32. Side effects and safety of Sandimmun in long term treatment of renal transplant patients
33. Cyclosporine-induced alterations in the hypothalamic gonadal axis in transplant patients
34. Cumulative side effects of cyclosporine and Ca antagonists: Hypergalactinemia, mastadenoma, and gynecomastia
35. Cyclosporine as a cause of unilateral gynecomastia in renal transplant recipient
36. Bilateral reduction mammoplasty in a patient treated with calcium channel blocker and cyclosporine after renal transplant
37. Effects of cyclosporine on ovarian function in sham-operated and pituitary-grafted young female rats
38. Cyclosporin A and multiple fibroadenomas of the breast
39. Gynecomastia
40. Gynecomastia: Pathomechanisms and treatment strategies
41. Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins
42. Pathophysiology of spironolactone-induced gynecomastia
43. Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects
44. Breast physiology in normal, lactating and disease states
45. Prolactin-secreting pituitary adenomas with mammary dysplasia in New Zealand white rabbits
46. Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drug
47. Prolactin receptors on human lymphocytes and their modulation by cyclosporine
48. Prolactin receptors on human T and B-lymphocytes: Antagonism of prolactin binding by cyclosporine
49. Mechanism of action of prolactin in the control of mammary gland function
50. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients